Literature DB >> 23727526

Cerebral ischemic injury is enhanced in a model of oculodentodigital dysplasia.

Michael G Kozoriz1, Simon Lai1, José L Vega2, Juan C Sáez3, Wun Chey Sin1, John F Bechberger1, Christian C Naus4.   

Abstract

Oculodentodigital dysplasia (ODDD) is a rare autosomal dominant disease that results in visible developmental anomalies of the limbs, face, eyes and teeth. Recently analysis of human connexin43 (Cx43) DNA sequences has revealed a number of different missense, duplication and frame shift mutations resulting in this phenotype. A mouse model of this disorder has been created with a missense point mutation of the glycine amino acid at position 60 to serine (G60S). Heterozygote +/G60S mice exhibit a similar ODDD phenotype as observed in humans. In addition to the malformations listed above, ODDD patients often have neurological findings. In the brain, Cx43 is highly expressed in astrocytes and has been shown to play a role in neuroprotection. We were interested in determining the effect of the +/G60S mutation following stroke. Four days after middle cerebral artery occlusion the volume of infarct was larger in mice with the +/G60S mutation. In astrocyte-neuron co-cultures, exposure to glutamate also resulted in greater cellular death in the +/G60S mutants. Protein levels of Cx43 in the mutant mouse were found to be reduced when compared to the normal tissue. Cx43 protein was observed as a continual line of small punctate aggregates in the plasma membrane with increased intracellular localization, which is distinct from the larger plaques seen in the normal mouse astrocytes. Functionally, primary +/G60S astrocytes exhibited reduced gap junctional coupling and increased hemichannel activity, which may underlie the mechanism of increased damage during stroke. This article is part of the Special Issue Section entitled 'Current Pharmacology of Gap Junction Channels and Hemichannels'. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4′,6-diamidino-2-phenylindole; Astrocytes; BSA; Connexin43; Cx43; DAPI; DMEM; Dulbecco's modified Eagle's medium; EBSS; Earle's balanced salt solution; Etd; G60S; GFAP; Gap junctional communication; HBSS; Hank's buffered salt solution; Hemichannels; IBA-1; LDH; La(3+); MCAO; ODDD; PI; RIPA; Rare genetic disease; Stroke; TBS-T; Tris-buffered saline with tween; bovine serum albumin; connexin43; ethidium; glial fibrillary acidic protein; ionized calcium-binding adaptor molecule 1; lactate dehydrogenase; lanthanum ion; middle cerebral artery occlusion; missense point mutation of the glycine amino acid at position 60 conversion to serine; oculodentodigital dysplasia; propidium iodide; radioimmune precipitation lysis buffer

Mesh:

Substances:

Year:  2013        PMID: 23727526     DOI: 10.1016/j.neuropharm.2013.05.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Acute connexin43 temporal and spatial expression in response to ischemic stroke.

Authors:  Moises Freitas-Andrade; Jennifer She; John Bechberger; Christian C Naus; Wun Chey Sin
Journal:  J Cell Commun Signal       Date:  2017-11-13       Impact factor: 5.782

Review 2.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

3.  Tonabersat Prevents Inflammatory Damage in the Central Nervous System by Blocking Connexin43 Hemichannels.

Authors:  Yeri Kim; Jarred M Griffin; Mohd N Mat Nor; Jie Zhang; Peter S Freestone; Helen V Danesh-Meyer; Ilva D Rupenthal; Monica Acosta; Louise F B Nicholson; Simon J O'Carroll; Colin R Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

4.  Gap junction intercellular communication mediated by connexin43 in astrocytes is essential for their resistance to oxidative stress.

Authors:  Hoa T Le; Wun Chey Sin; Shannon Lozinsky; John Bechberger; José Luis Vega; Xu Qiu Guo; Juan C Sáez; Christian C Naus
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

5.  Targeting MAPK phosphorylation of Connexin43 provides neuroprotection in stroke.

Authors:  Moises Freitas-Andrade; Nan Wang; John F Bechberger; Marijke De Bock; Paul D Lampe; Luc Leybaert; Christian C Naus
Journal:  J Exp Med       Date:  2019-03-14       Impact factor: 14.307

Review 6.  Diseases associated with leaky hemichannels.

Authors:  Mauricio A Retamal; Edison P Reyes; Isaac E García; Bernardo Pinto; Agustín D Martínez; Carlos González
Journal:  Front Cell Neurosci       Date:  2015-07-27       Impact factor: 5.505

7.  Danegaptide Enhances Astrocyte Gap Junctional Coupling and Reduces Ischemic Reperfusion Brain Injury in Mice.

Authors:  Moises Freitas-Andrade; John Bechberger; Jasmine Wang; Ken K C Yeung; Shawn N Whitehead; Rie Shultz Hansen; Christian C Naus
Journal:  Biomolecules       Date:  2020-02-26

8.  Beneficial and Detrimental Remodeling of Glial Connexin and Pannexin Functions in Rodent Models of Nervous System Diseases.

Authors:  Lucila Brocardo; Luis Ernesto Acosta; Ana Paula Piantanida; Lorena Rela
Journal:  Front Cell Neurosci       Date:  2019-11-06       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.